pBb plasmids were prepared as the BglBrick standard expression vectors25 (link). The top portion of the mevalonate pathway contains genes for the conversion of acetyl CoA to mevalonate: acetoacetyl-CoA synthase from E. coli (atoB), HMG-CoA synthase from S. cerevisiae (HMGS), and an amino-terminal truncated version of HMG-CoA reductase from S. cerevisiae (HMGR). The bottom portion of the mevalonate pathway contains genes for the conversion of mevalonate toFPP: mevalonate kinase from S. cerevisiae (MK), phosphomevalonate kinase from S. cerevisiae (PMK), phosphomevalonate decarboxylase from S. cerevisiae (PMD), IPP isomerase from E. coli (idi), and farnesyl diphosphate synthase from E. coli (ispA). pJBEI-2704 (pBbA5c-MevT-MBIS): The construction of this plasmids has been previously reported12 (link). pJBEI-2997 (pBbA5c-MevT(CO)-MBIS(CO)): pBbA5c-MevT(CO) was constructed by ligating pBbA5c vector (BamHI/XhoI) and BglBrick compatible codon optimized HMGS and HMGR inserts (BglII/XhoI), using BglBrick cloning strategy with compatible BglII and BamHI restriction. Individual genes were PCR-amplified from pAM45 (ref. 16 (link)) with primers contain EcoRI and BglII sites at 5′-end and BamHI and XhoI sites at 3′-end of each gene. The BglBrick restriction sites found in each gene were removed by site-specific mutagenesis. pBbA5c-MevT(CO)-MBIS(CO) was prepared by the ligation of pBbA5c-MevT(CO) vector (BamHI/XhoI) and MBIS with E. coli codon optimized MK and PMK insert (BglII/XhoI). pJBEI-2999 (pBbA5c-MevT(CO)-Ptrc-MBIS(CO)): The plasmid was prepared by two-step ligation of pBbA5c-MevT(CO) vector (BamHI/XhoI) and a double terminator-Ptrc gene part (BglII/XhoI) and MBIS(CO) insert (BglII/XhoI) by standard BglBrick cloning strategy.
>
Chemicals & Drugs
>
Amino Acid
>
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent is an enzyme that catalyzes the conversion of 3-hydroxy-3-methylglutaryl-CoA to mevalonate, a key step in the cholesterol biosynthesis pathway.
This NADP-dependent enzyme plays a crucial role in regulating cholesterol levels in the body.
Optimizing research and protocols related to this enzyme can lead to advancements in the understanding and treatment of cholestrol-related disorders.
PubCompare.ai's AI-driven tool can help researchers quickly locate the best protocols from literature, preprints, and patents, streamlining the research process and identifying the ideal products for their expereinces.
This NADP-dependent enzyme plays a crucial role in regulating cholesterol levels in the body.
Optimizing research and protocols related to this enzyme can lead to advancements in the understanding and treatment of cholestrol-related disorders.
PubCompare.ai's AI-driven tool can help researchers quickly locate the best protocols from literature, preprints, and patents, streamlining the research process and identifying the ideal products for their expereinces.
Most cited protocols related to «3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent»
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
acetoacetyl CoA
Carboxy-Lyases
Cloning Vectors
Codon
Coenzyme A, Acetyl
Deoxyribonuclease EcoRI
Escherichia coli
Gene Conversion
Genes
Genes, Duplicate
Geranyltranstransferase
Hydroxymethylglutaryl-CoA Synthase
isopentenyldiphosphate delta-isomerase
Ligation
Mevalonate
mevalonate kinase
Mutagenesis, Site-Directed
Nitric Oxide Synthase
Oligonucleotide Primers
phosphomevalonate
phosphomevalonate kinase
Plasmids
Saccharomyces cerevisiae
An overview of the plasmids constructed in this study is reported in Table
2 , the detailed maps of the plasmids are contained in Additional file
1 . The gene coding for α-santalene synthase (SanSynopt) was codon optimized for expression in S. cerevisiae and synthesized by DNA 2.0 (Menlo Park, CA, USA) (Additional file
2 ), cut with NotI/PacI and ligated into NotI/PacI restricted vector pICK01 containing tHMG1[12 (link)] resulting in plasmid pISP15 (Figure
1 ).
To simultaneously integrate multiple genes into the yeast genome a series of plasmids containing the genes, constitutive strong promoters, terminators, marker gene sequences and the required region for genomic integration were constructed. All endogenous S. cerevisiae genes were PCR amplified using genomic DNA of strain CEN.PK113-5D as template. Primers used for amplification are provided in Additional file
3 . All PCRs were performed using high fidelity Phusion™ DNA polymerase (Finnzymes, Vantaa, Finland). The ERG20 gene [GenBank: NM_001181600] was amplified using primer pair 1/2, subsequently digested with BamHI/NheI and ligated into the vector pSP-GM2
[55 (link)] restricted with the respective enzymes downstream of the TEF1 promoter resulting in plasmid pIGS01. A 711 bp upstream flanking region (AD1) selected for genomic integration was amplified using primer pair 3/4, cut with MreI/Kpn2I and ligated into vector pIGS01 restricted with the respective enzymes resulting in plasmid pIGS02. Plasmid pIGS03 was obtained by cloning gene GDH2 [GenBank: NM_001180275] amplified with primer pair 5/6 into pIGS02 downstream of the PGK1 promoter using PacI/NotI restriction sites. A downstream flanking region of 653 bp (AD2) was amplified with primers 7/8, digested with AscI/AvrII and ligated into pIGS03. The resulting plasmid was named pIGS04. To complete the plasmid for integration the Kluyveromyces lactis (Kl) URA3 gene [GenBank: Y00454] was amplified with primers 9 and 10 using plasmid pWJ1042
[56 (link)] as template, cut with FseI and ligated into pIGS04 after restriction with the respective enzyme. The resulting plasmid was designated pIGS05, digested with MreI/AscI and the resulting fragment used for integration into the yeast genome as described below. The 5´ region of the Kl URA3 gene was amplified with primers 11 and 12, cut with AvrII/AscI and cloned into pIGS03 restricted with the respective enzymes resulting in plasmid pIGS06. Amplification of the catalytic domain of the HMG-CoA reductase gene (tHMG1) [GenBank: NM_001182434] was performed using primer pair 13/14, the resulting fragment cleaved with NheI/BamHI and cloned downstream of the TEF1 promoter into NheI/BamHI restricted pSP-GM2 resulting in pIGS07. A mutant allele upc2-1 of the UPC2 gene [GenBank: NC_001180521] was created by use of primer pair 15/16. To introduce the pleiotropic mutation G888D, the corresponding codon GGT was mutated to GAT generating the amino acid substitution. Subsequently, the PCR amplified upc2-1 was cloned downstream of the PGK1 promoter into pIGS07 using NotI/PacI resulting in plasmid pIGS08. An 829 bp downstream flanking region (AD3) selected for genomic integration was amplified using primer pair 17/18 cut with MreI/Kpn2I and ligated into vector pIGS08 restricted with the respective enzymes resulting in plasmid pIGS09. The 3´ region of Kl URA3 (overlapping with the 5´region described above) was amplified with primers 19 and 20, cut with AvrII/AscI and cloned into pIGS09 restricted with the respective enzymes resulting in plasmid pIGS10. All plasmids were verified by sequencing (Sigma-Aldrich, St. Luis, MO). Subsequently, plasmids pIGS06 and pIGS10 were restricted with MreI/AscI, the cassettes isolated from the vector backbone and used for yeast transformation (see below).
To simultaneously integrate multiple genes into the yeast genome a series of plasmids containing the genes, constitutive strong promoters, terminators, marker gene sequences and the required region for genomic integration were constructed. All endogenous S. cerevisiae genes were PCR amplified using genomic DNA of strain CEN.PK113-5D as template. Primers used for amplification are provided in Additional file
[55 (link)] restricted with the respective enzymes downstream of the TEF1 promoter resulting in plasmid pIGS01. A 711 bp upstream flanking region (AD1) selected for genomic integration was amplified using primer pair 3/4, cut with MreI/Kpn2I and ligated into vector pIGS01 restricted with the respective enzymes resulting in plasmid pIGS02. Plasmid pIGS03 was obtained by cloning gene GDH2 [GenBank: NM_001180275] amplified with primer pair 5/6 into pIGS02 downstream of the PGK1 promoter using PacI/NotI restriction sites. A downstream flanking region of 653 bp (AD2) was amplified with primers 7/8, digested with AscI/AvrII and ligated into pIGS03. The resulting plasmid was named pIGS04. To complete the plasmid for integration the Kluyveromyces lactis (Kl) URA3 gene [GenBank: Y00454] was amplified with primers 9 and 10 using plasmid pWJ1042
[56 (link)] as template, cut with FseI and ligated into pIGS04 after restriction with the respective enzyme. The resulting plasmid was designated pIGS05, digested with MreI/AscI and the resulting fragment used for integration into the yeast genome as described below. The 5´ region of the Kl URA3 gene was amplified with primers 11 and 12, cut with AvrII/AscI and cloned into pIGS03 restricted with the respective enzymes resulting in plasmid pIGS06. Amplification of the catalytic domain of the HMG-CoA reductase gene (tHMG1) [GenBank: NM_001182434] was performed using primer pair 13/14, the resulting fragment cleaved with NheI/BamHI and cloned downstream of the TEF1 promoter into NheI/BamHI restricted pSP-GM2 resulting in pIGS07. A mutant allele upc2-1 of the UPC2 gene [GenBank: NC_001180521] was created by use of primer pair 15/16. To introduce the pleiotropic mutation G888D, the corresponding codon GGT was mutated to GAT generating the amino acid substitution. Subsequently, the PCR amplified upc2-1 was cloned downstream of the PGK1 promoter into pIGS07 using NotI/PacI resulting in plasmid pIGS08. An 829 bp downstream flanking region (AD3) selected for genomic integration was amplified using primer pair 17/18 cut with MreI/Kpn2I and ligated into vector pIGS08 restricted with the respective enzymes resulting in plasmid pIGS09. The 3´ region of Kl URA3 (overlapping with the 5´region described above) was amplified with primers 19 and 20, cut with AvrII/AscI and cloned into pIGS09 restricted with the respective enzymes resulting in plasmid pIGS10. All plasmids were verified by sequencing (Sigma-Aldrich, St. Luis, MO). Subsequently, plasmids pIGS06 and pIGS10 were restricted with MreI/AscI, the cassettes isolated from the vector backbone and used for yeast transformation (see below).
Full text: Click here
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Alleles
Amino Acid Substitution
Catalytic Domain
Cloning Vectors
Codon
DNA-Directed DNA Polymerase
DNA Restriction Enzymes
Enzymes
Gene Amplification
Genes
Genes, vif
Genome
Kluyveromyces lactis
Microtubule-Associated Proteins
Multiple Birth Offspring
Mutation
Nitric Oxide Synthase
Oligonucleotide Primers
Plasmids
Saccharomyces cerevisiae
Strains
Vertebral Column
The mvaS (HMG-CoA synthase, GenBank No. AAG02439) and mvaE (acetyl-CoA acetyltransferase/HMG-CoA reductase, GenBank No. AAG02438) genes from E. faecalis were chemically synthesized by Genray Company with plasmid pGH as vector (named pGH/mvaS, pGH/mvaE). The mvaE was obtained by PCR using the primers mvaE-F (5′-CATGCCATGGAGGAGGTAAAAAAACATGAAAACAGTAGTTATTATTGATGC-3′ ) and mvaE-R (5′-CGCGGATCCTTATTGTTTTCTTAAATCATTTAAAATAG-3′ ) and pGH/mvaE as a template. The isolated mvaE gene fragment was excised using NcoI and BamHI, followed by insertion into the corresponding sites of pACYCDuet-1 or pYJM8 to create pYJM15 and pYJM18 respectively. The mvaS gene was obtained by PCR using the primers mvaS-F (5′-CCAGAGCTCAGGAGGTAAAAAAACATGACAATTGG GATTGATAAAATTA-3′ ) and mvaS-R (5′-CAACTGCAGTTAGTTTCGATAAGAGCGAA CG-3′) and pGH/mvaS as a template. The product of mvaS was introduced behind the mvaE gene of pYJM15 or pYJM18 after restriction with SacI and PstI to create pYJM16 (Fig.2A ) and pYJM20 (Fig.2C ).
Full text: Click here
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Acetyl-CoA C-Acetyltransferase
AVM protocol
Cloning Vectors
Genes
Hydroxymethylglutaryl-CoA Synthase
Oligonucleotide Primers
Plasmids
In this experiment, simvastatin was used in three dosing regimens (10, 20 or 40 mg/kg per os) that were previously shown as efficient to protect against the single median lethal dose (LD50) of LPS (22, 15 mg/kg ip) in rats10 (link). Also, those doses of simvastatin are in compliance to previously employ in rat/murine studies in vivo (typically 10–100 mg/kg/day). On the other hand, due to significant up-regulation of HMG-CoA reductase’s activity by cause of statin treatment in rodents11 (link),20 (link),21 (link), the same doses are higher compared to recommend for the treatment of men.
To induce experimental sepsis the animals were challenged with a non-lethal single dose of LPS ip (0.25 LD50/kg), a model that exhibits the strongest inflammatory effects in various animal models for acute systemic inflammation, including immune cell infiltration, oxidative stress and apoptosis of organ tissues9 (link),10 (link),29 (link).
Wistar rats were randomly divided into five experimental groups each containing six individuals. The animals received the following treatments: (1) Control (0.5% methylcellulose 1 ml/kg ip), (2) LPS (endotoxin 5.5 mg/kg ip), (3) simvastatin 10 (10 mg/kg per os) + LPS (endotoxin 5.5 mg/kg ip), (4) simvastatin 20 (20 mg/kg per os) + LPS (endotoxin 5.5 mg/kg ip), and (5) simvastatin 40 (40 mg/kg per os) + LPS (endotoxin 5.5 mg/kg ip). Simvastatin was given orally via oral gavage for 5 days, and 1.5 h afterwards the last dose of simvastatin LPS was administered at a single dose. The animals in LPS group received the same volume (1 ml/kg) of 0.5% methylcellulose for 5 days, as a vehicle, before endotoxin injection. In the control group, an identical volume of vehicle was given, without simvastatin or LPS. After LPS administration, the animals were observed continuously for 48 hrs.
To induce experimental sepsis the animals were challenged with a non-lethal single dose of LPS ip (0.25 LD50/kg), a model that exhibits the strongest inflammatory effects in various animal models for acute systemic inflammation, including immune cell infiltration, oxidative stress and apoptosis of organ tissues9 (link),10 (link),29 (link).
Wistar rats were randomly divided into five experimental groups each containing six individuals. The animals received the following treatments: (1) Control (0.5% methylcellulose 1 ml/kg ip), (2) LPS (endotoxin 5.5 mg/kg ip), (3) simvastatin 10 (10 mg/kg per os) + LPS (endotoxin 5.5 mg/kg ip), (4) simvastatin 20 (20 mg/kg per os) + LPS (endotoxin 5.5 mg/kg ip), and (5) simvastatin 40 (40 mg/kg per os) + LPS (endotoxin 5.5 mg/kg ip). Simvastatin was given orally via oral gavage for 5 days, and 1.5 h afterwards the last dose of simvastatin LPS was administered at a single dose. The animals in LPS group received the same volume (1 ml/kg) of 0.5% methylcellulose for 5 days, as a vehicle, before endotoxin injection. In the control group, an identical volume of vehicle was given, without simvastatin or LPS. After LPS administration, the animals were observed continuously for 48 hrs.
Full text: Click here
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Animal Model
Animals
Apoptosis
Cells
Endotoxins
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Inflammation
Methylcellulose
Mus
Oxidative Stress
Rats, Wistar
Septicemia
Simvastatin
Treatment Protocols
Tube Feeding
Three cognitive tests (verbal–numerical reasoning, memory and reaction time) were administered using a touch screen.5–7 (link) These tests cover domains that have been shown to be sensitive to change over time and are widely used in studies of ageing and brain disorders.8–10 (link) For verbal–numerical reasoning, participants were asked to solve as many multiple choice questions as possible (maximum 13) within 2 min. Performance was assessed as the total number of correct responses. Memory was assessed using the pairs matching test in which participants had to remember 6 pairs of shapes and their locations displayed for 5 s. Performance was assessed as the total number of errors made in matching all six pairs. Reaction time was measured by pressing a button as quickly as possible when two identical shapes were presented. Performance was assessed as the mean reaction time (ms) of eight trials for correctly identified matching pairs.
Medications and diagnoses were obtained by nurse-led interview. Only regular medications and health supplements taken weekly, monthly or three monthly were recorded. Medications were recorded using 6745 categories adapted from Read code V.3 (CTV3) used in the general practice in the UK. Of these, 1192 medications were taken by 30 or more participants and were classified using the Anatomical Therapeutic Chemical classification11 as a backbone. For example, brand names with different doses were allocated into their chemical substance (eg, Lipitor and atorvastatin were treated as atorvastatin), chemical subgroup (eg, HMG CoA reductase), therapeutic subgroup (eg, lipid modifying agents) and anatomical group (eg, cardiovascular system). Compound medications were divided into single chemical substances (eg, CoAprovel into irbesartan and hydrochlorothiazide). Duration and dosage of the medications were not collected by UK Biobank and hence not available for analysis.
Demographic and lifestyle variables included in the model were age, gender, education, household income, smoking, alcohol status, psychostimulant/nootropic medication use and assessment centre.
Medications and diagnoses were obtained by nurse-led interview. Only regular medications and health supplements taken weekly, monthly or three monthly were recorded. Medications were recorded using 6745 categories adapted from Read code V.3 (CTV3) used in the general practice in the UK. Of these, 1192 medications were taken by 30 or more participants and were classified using the Anatomical Therapeutic Chemical classification11 as a backbone. For example, brand names with different doses were allocated into their chemical substance (eg, Lipitor and atorvastatin were treated as atorvastatin), chemical subgroup (eg, HMG CoA reductase), therapeutic subgroup (eg, lipid modifying agents) and anatomical group (eg, cardiovascular system). Compound medications were divided into single chemical substances (eg, CoAprovel into irbesartan and hydrochlorothiazide). Duration and dosage of the medications were not collected by UK Biobank and hence not available for analysis.
Demographic and lifestyle variables included in the model were age, gender, education, household income, smoking, alcohol status, psychostimulant/nootropic medication use and assessment centre.
Full text: Click here
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Atorvastatin
Brain Diseases
Cardiovascular System
Cognitive Testing
Diagnosis
Dietary Supplements
Drug Compounding
Ethanol
Gender
Households
Hydrochlorothiazide
Irbesartan
Lipids
Lipitor
Memory
Nootropic Agents
Nurses
Pharmaceutical Preparations
Therapeutics
Touch
Vertebral Column
Most recents protocols related to «3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent»
Soybean saplings' plant shoots and roots as well as the 30-day-old fresh rosette leaves of A. thaliana were chosen to measure HMGR enzyme activity. The 0.1 g samples were collected and used for enzyme assays according to the protocol described by the Plant HMG-CoA reductase (HMGR) ELISA Kit (Wuhan Chundu Biotechnology, China).
Full text: Click here
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Enzyme-Linked Immunosorbent Assay
enzyme activity
Enzyme Assays
Plant Roots
Plants
Plant Shoots
Soybeans
Isothermal calorimetry (ITC) studies were performed on a nano-ITC instrument (TA Instruments). In order to facilitate pure substrate binding measurements and to avoid the reaction generated by HMG CoA reduction to mevalonate, the thermodynamic properties of HMGCR binding with pravastatin were analyzed (38 (link)). HMG CoA reductase WT and mutant protein at a concentration of 20 µM in Buffer B supplemented with 1 mM NADPH in the reaction cell were injected with 50 µM pravastatin in Buffer B supplemented with 1 mM NADPH using the multiple injection mode for a total 20 7-µL injections. Heat data were plotted using Nano Analyze software™.
3-hydroxy-3-methylglutaryl-coenzyme A
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Buffers
Calorimetry
Cells
HMGCR protein, human
Mevalonate
Mutant Proteins
NADP
Pravastatin
HMG CoA reductase enzymatic activity was assessed by a colorimetric assay. HMG CoA reductase reactions were set up in 96 well plates, with each well containing a total volume of 100 µL Buffer E, supplemented with 400 µM NADPH (sigma) and 2 µL of either WT or mutant-purified HMG CoA reductase protein (0.6 mg/mL), WT enzyme with pravastatin, or a no enzyme control. Reactions were initiated by the addition of HMG-CoA substrate to a final concentration of 0 to 400 µM. Immediately after the addition of HMG-CoA, plates were analyzed for 340 nm absorbance using an Infinite M200 plate reader (Tecan). Absorbance was monitored every 30 s for a total of 90 min. For repeat experiments, HMG CoA was added to either WT or mutant reactions in an alternating fashion in order to minimize technical variations of V0.
3-hydroxy-3-methylglutaryl-coenzyme A
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Biological Assay
Buffers
Colorimetry
enzyme activity
Enzymes
M-200
Mutant Proteins
NADP
Pravastatin
The levels of TC and TG were assayed using commercial kits according to the manufacturer’s instructions. HDL-C and LDL-C were measured in serum using ARCHITECT C4000 Biochemistry Analyzer. Plasma Lipoprotein lipase (LPL) was measured as previously described (Hamilton et al., 1998 (link); Mondragon et al., 2014 (link)). In this assay, the rats received 300 U/kg heparin intravenously and blood was collected after 15 min for the separation of plasma. LPL activity was calculated as total lipase minus the remaining activity after inhibition with 1 M NaCl. HMG-CoA reductase activity was determined in the liver as previously described (Rao and Ramakrishnan, 1975 (link)). The atherogenic index (AI) was calculated using the following equation (Wu et al., 2014 (link)).
MDA was assayed in serum samples according to Okhawa et al. (1979) (link). This method uses the reaction of MDA with TBA and an MDA standard curve. GSH content was determined as previously reported (Ellman, 1959 (link)). SOD activity was determined depending on its ability to inhibit superoxide radical formation in a reaction mixture containing xanthine and xanthine oxidase (XO). The activity of XO produces superoxide that reacts with hydroxylamine to form nitrite that could be detected by Griess reagent (Ōyanagui, 1984 (link)). CAT activity was measured based on the enzyme-catalyzed decomposition of hydrogen peroxide (H2O2), whereby the residual H2O2 was determined (Işlekel et al., 1999 (link)). The assay of GPx activity was based on the decomposition of H2O2 to water and oxygen and the oxidation of GSH. The oxidized glutathione is reduced by glutathione reductase and the decrease in NADPH is monitored (Flohé and Günzler, 1984 (link)).
MDA was assayed in serum samples according to Okhawa et al. (1979) (link). This method uses the reaction of MDA with TBA and an MDA standard curve. GSH content was determined as previously reported (Ellman, 1959 (link)). SOD activity was determined depending on its ability to inhibit superoxide radical formation in a reaction mixture containing xanthine and xanthine oxidase (XO). The activity of XO produces superoxide that reacts with hydroxylamine to form nitrite that could be detected by Griess reagent (Ōyanagui, 1984 (link)). CAT activity was measured based on the enzyme-catalyzed decomposition of hydrogen peroxide (H2O2), whereby the residual H2O2 was determined (Işlekel et al., 1999 (link)). The assay of GPx activity was based on the decomposition of H2O2 to water and oxygen and the oxidation of GSH. The oxidized glutathione is reduced by glutathione reductase and the decrease in NADPH is monitored (Flohé and Günzler, 1984 (link)).
Full text: Click here
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
Atherogenesis
Biological Assay
BLOOD
Cardiac Arrest
Enzymes
Glutathione Disulfide
Glutathione Reductase
Griess reagent
Heparin
Hydroxylamine
Lipase
Liver
LPL protein, human
NADP
Nitrites
Oxygen
Peroxide, Hydrogen
Plasma
Psychological Inhibition
Rattus
Serum
Sodium Chloride
Superoxides
Xanthine
Xanthine Oxidase
The effect of the EA fraction on the activities of HMG-CoA reductase and PL was tested in vitro. The assay of the activity of HMG-CoA reductase is based on NADPH oxidation by the catalytic subunit of HMG reductase in the presence of HMG-CoA (Rao and Ramakrishnan, 1975 (link)) using pravastatin as a standard inhibitor. PL activity was measured using 4-methyl umbelliferone oleate (4 MUO) as a substrate. Using microplate reader at an excitation wavelength of 320 nm and an emission wavelength of 450 nm, the amount of 4-MUO liberated by lipase was measured.
Full text: Click here
3-hydroxy-3-methylglutaryl-coenzyme A
3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
7-hydroxycoumarin
Biological Assay
Catalytic Domain
Lipase
methyl oleate
NADP
Oxidoreductase
Pravastatin
Top products related to «3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent»
Sourced in United States, Spain
The HMG-CoA reductase assay kit is a laboratory equipment product designed to measure the activity of the enzyme HMG-CoA reductase. HMG-CoA reductase is a key enzyme involved in the biosynthesis of cholesterol. The assay kit provides the necessary reagents and protocols to quantify the enzymatic activity of HMG-CoA reductase in biological samples.
Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.
Sourced in United States, Germany, China, United Kingdom, France, Sao Tome and Principe, Japan, Slovenia, Sweden, Italy
Simvastatin is a laboratory instrument used for the analysis and measurement of chemical compounds. It is designed to accurately quantify the presence and concentration of specific substances in a given sample. The core function of Simvastatin is to provide precise and reliable data for research and scientific applications.
Sourced in United States, Germany, United Kingdom, India, Japan, Sao Tome and Principe, China, France, Spain, Canada, Switzerland, Italy, Australia, Israel, Brazil, Belgium, Poland, Hungary, Macao
Cholesterol is a lab equipment product that measures the concentration of cholesterol in a given sample. It provides quantitative analysis of total cholesterol, HDL cholesterol, and LDL cholesterol levels.
Sourced in United States, Germany, United Kingdom, Japan, Lithuania, France, Italy, China, Spain, Canada, Switzerland, Poland, Australia, Belgium, Denmark, Sweden, Hungary, Austria, Ireland, Netherlands, Brazil, Macao, Israel, Singapore, Egypt, Morocco, Palestine, State of, Slovakia
The High-Capacity cDNA Reverse Transcription Kit is a laboratory tool used to convert RNA into complementary DNA (cDNA) molecules. It provides a reliable and efficient method for performing reverse transcription, a fundamental step in various molecular biology applications.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in Japan, China, United States, France, Germany, Switzerland, Canada, Sweden, Italy, Puerto Rico, Singapore
The PrimeScript RT reagent kit is a reverse transcription kit designed for the synthesis of first-strand cDNA from RNA templates. The kit includes RNase-free reagents and enzymes necessary for the reverse transcription process.
Sourced in United States, Germany, Italy, Spain, France, India, China, Poland, Australia, United Kingdom, Sao Tome and Principe, Brazil, Chile, Ireland, Canada, Singapore, Switzerland, Malaysia, Portugal, Mexico, Hungary, New Zealand, Belgium, Czechia, Macao, Hong Kong, Sweden, Argentina, Cameroon, Japan, Slovakia, Serbia
Gallic acid is a naturally occurring organic compound that can be used as a laboratory reagent. It is a white to light tan crystalline solid with the chemical formula C6H2(OH)3COOH. Gallic acid is commonly used in various analytical and research applications.
Sourced in United States, Germany, Italy, India, France, Poland, Spain, China, Chile, Sao Tome and Principe, United Kingdom, Switzerland, Australia, Brazil, Canada, Singapore, Portugal, Mexico, Malaysia, New Zealand, Macao, Croatia, Belgium, Lithuania, Romania, Argentina, Finland
The Folin-Ciocalteu reagent is a colorimetric reagent used for the quantitative determination of phenolic compounds. It is a mixture of phosphomolybdic and phosphotungstic acid complexes that undergo a color change when reduced by phenolic compounds.
Sourced in United States, United Kingdom, Germany, China, Canada, Japan, Macao, Italy, Sao Tome and Principe, Israel, Spain, Denmark, France, Finland, Australia, Morocco, Ireland, Czechia, Sweden, Uruguay, Switzerland, Netherlands, Senegal
β-actin is a protein that is found in all eukaryotic cells and is involved in the structure and function of the cytoskeleton. It is a key component of the actin filaments that make up the cytoskeleton and plays a critical role in cell motility, cell division, and other cellular processes.
More about "3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent"
Exploring the Crucial Role of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase, NADP-dependent in Cholesterol Regulation
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, NADP-dependent is a pivotal enzyme in the cholesterol biosynthesis pathway.
This NADP-dependent enzyme catalyzes the conversion of HMG-CoA to mevalonate, a key step in the production of cholesterol.
By regulating this enzyme, researchers can optimize cholesterol levels and address related disorders.
The HMG-CoA reductase assay kit provides a convenient way to measure the activity of this enzyme, while the RNeasy Mini Kit can be used to isolate high-quality RNA for expression studies.
Simvastatin, a widely-used statin drug, works by inhibiting HMG-CoA reductase to lower cholesterol levels.
Understanding the relationship between HMG-CoA reductase, NADP-dependent and cholesterol is crucial for advancements in the field.
The High-Capacity cDNA Reverse Transcription Kit and TRIzol reagent can be used to study gene expression, while the PrimeScript RT reagent kit facilitates reverse transcription.
Gallic acid and the Folin-Ciocalteu reagent can be employed to measure antioxidant activity, which may be relevant to cholesterol-related conditions.
By leveraging AI-powered tools like PubCompare.ai, researchers can quickly locate the best protocols and resources to streamline their HMG-CoA reductase, NADP-dependent research.
This optimization can lead to breakthroughs in understanding and treating cholesterol-related disorders, ultimately benefiting patient care.
The β-actin gene is commonly used as a reference for normalization in gene expression studies related to this enzyme.
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, NADP-dependent is a pivotal enzyme in the cholesterol biosynthesis pathway.
This NADP-dependent enzyme catalyzes the conversion of HMG-CoA to mevalonate, a key step in the production of cholesterol.
By regulating this enzyme, researchers can optimize cholesterol levels and address related disorders.
The HMG-CoA reductase assay kit provides a convenient way to measure the activity of this enzyme, while the RNeasy Mini Kit can be used to isolate high-quality RNA for expression studies.
Simvastatin, a widely-used statin drug, works by inhibiting HMG-CoA reductase to lower cholesterol levels.
Understanding the relationship between HMG-CoA reductase, NADP-dependent and cholesterol is crucial for advancements in the field.
The High-Capacity cDNA Reverse Transcription Kit and TRIzol reagent can be used to study gene expression, while the PrimeScript RT reagent kit facilitates reverse transcription.
Gallic acid and the Folin-Ciocalteu reagent can be employed to measure antioxidant activity, which may be relevant to cholesterol-related conditions.
By leveraging AI-powered tools like PubCompare.ai, researchers can quickly locate the best protocols and resources to streamline their HMG-CoA reductase, NADP-dependent research.
This optimization can lead to breakthroughs in understanding and treating cholesterol-related disorders, ultimately benefiting patient care.
The β-actin gene is commonly used as a reference for normalization in gene expression studies related to this enzyme.